Industry: Pharmaceuticals, Biotechnology
Transport Pharmaceuticals, Inc. is developing a proprietary electrokinetic drug delivery technology applicable to multiple dermatological diseases, with an initial focus on herpes labialis, or cold sores. The Company’s lead product enables the delivery of high doses of acyclovir, an approved cold sore treatment, directly to impacted skin areas, addressing a primary barrier to effective treatment of herpes labialis. The Company operates under the management of neXus therapeutics, inc., a biopharmaceutical management company that employs an “essential product development” paradigm to enhance the development process of early stage drugs and combination products. ( www.transportpharma.com )
Transport Pharmaceuticals , Inc.
161 Worcester Road Suite 402
Framingham, Massachusetts 01701
USA
Tel: (508) 872-0433
Fax: (508) 872-0922